References

  1. Crane F, Hatefi Y, Lester R, Widmer C (1957). "Isolation of a quinone from beef heart mitochondria". Biochim Biophys Acta 25 (1): 220–1.
  2. The coenzyme Q10 content of the average Danish die...[Int J Vitam Nutr Res. 1997]
  3. Zmitek et al. (2008) Agro Food Ind. Hi Tec. 19, 4, 9. - Improving the bioavailability of CoQ10
  4. H. N. Bhagavan and R. K. Chopra, Mitochondrion, 7: S78-S88 (2007)
  5. Coles L, Harris S (1996). "Coenzyme Q-10 and Lifespan Extension." Advances in Anti-Aging Medicine. 1  (1): 205-215
  6. Peter H. Langsjoen, University of Washington, INTRODUCTION TO COENZYME Q10 http://faculty.washington.edu/ely/coenzq10.html
  7. Sándor PS, et al. (2005). "Efficacy of coenzyme Q10 in migraine prophylaxis: A randomized controlled trial". Neurology  64: 713–715.
  8. Katsuhisa Sakano, Mami Takahashi, Mitsuaki Kitano, Takashi Sugimura, Keiji Wakabayashi: Suppression of Azoxymethane-induced Colonic Premalignant Lesion Formation by Coenzyme Q10 in Rats. Asian Pacific J Cancer Prev, 7, 599-603, 2006
  9. Rosenfeldt FL, Haas SJ, Krum H, Hadj A, Ng K, Leong J-Y, Watts GF. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. J Human Hypertension 21: 297-306, 2007
  10. Mortensen S.A., Vadhanavikit S., Folkers K. (1984)   Deficiency of coenzyme Q10 in myocardial failure.  In:  Drugs Exptl. Clin. Res. X(7) 497-502.
  11. Hiasa Y., Ishida T., Maeda T., Iwanc K., Aihara T., and Mori H. (1984) Effects of coenzyme Q10 on exercise tolerance in patients with stable angina pectoris.  In:   Biomedical and Clinical Aspects of Coenzyme Q, vol. 4 (1984) Folkers K., Yamamura Y., (eds) Elsevier, Amsterdam, pp 291-301.
  12. Kamikawa T., Kobayashi A., Yamashita T., Hayashi H., and Yamazaki N. (1985) Effects of coenzyme Q10 on exercise tolerance in chronic stable angina pectoris.  In:  Am. J. Cardiol.; 56:247-251.
  13. Langsjoen Per.H., Vadhanavikit S., Folkers K. (1985)  Response of patients in classes III and IV of cardiomyopathy  to therapy in a blind and crossover trial with coenzyme Q10. In:  Proc. Natl. Acad. of Sci., U.S.A., vol. 82, pp 4240-4244.
  14. Judy W.V., Hall J.H., Toth P.D., Folkers K. (1986) Double  blind-double crossover study of coenzyme Q10 in heart failure.  In:  Folkers K., Yamamura Y. (eds) Biomedical and clinical aspects of coenzyme Q, vol. 5.  Elsevier,  Amsterdam, pp 315-323.
  15. Rossi E., Lombardo A., Testa M., Lippa S., Oradei A.,  Littarru G.P., Lucente M. Coppola E., Manzoli U.  Coenzyme  Q10 in ischaemic cardiopathy. In:  Biomedical and Clinical Aspects of Coenzyme Q, vol. 6 (1991) Folkers K., Yamagami  T., and Littarru G. P. (eds) Elsevier, Amsterdam, pp 321-326.
  16. Morisco C., Trimarco B., Condorelli M.  Effect of coenzyme  Q10 therapy in patients with congestive heart failure: A  long-term multicenter randomized study.  In:  Seventh  International Symposium on Biomedical and Clinical Aspects of Coenzyme Q  Folkers K., Mortensen S.A., Littarru G.P., Yamagami T., and Lenaz G. (eds) The Clinical Investigator, (1993) 71:S  34-S 136.
  17. Schneeberger W., Muller-Steinwachs J., Anda L.P., Fuchs  W., Zilliken F., Lyson K., Muratsu K., and Folkers K. A clinical double blind and crossover trial with coenzyme Q10 on patients with cardiac disease.  In:  Biomedical and Clinical Aspects of Coenzyme Q, vol. 5 (1986) Folkers K., Yamamura Y., (eds) Elsevier, Amsterdam, pp 325-333.
  18. Schardt F., Welzel D., Schiess W., and Toda K. Effect of coenzyme Q10 on ischaemia-induced ST-segment depression:  A double blind, placebo-controlled crossover study.  In: Biomedical and Clinical Aspects of Coenzyme Q, vol. 6 (1991) Folkers K., Yamagami T., and Littarru G. P. (eds) Elsevier, Amsterdam, pp 385-403.
  19. Swedberg K., Hoffman-Berg C., Rehnqvist N., Astrom H.  (1991) Coenzyme Q10 as an adjunctive in treatment of  congestive heart failure.  In: 64th Scientific Sessions American Heart Association, Abstract 774-6.
  20. Mellstedt H., Osterborg A., Nylander M., Morita M., and Folkers K.  A deficiency of coenzyme Q10 (CoQ10) in conventional cancer therapy and blood levels of CoQ10 in cancer patients in Sweden.  In:  Eighth International Symposium on Biomedical and Clinical Aspects of Coenzyme Q (1994) The Molecular Aspects of Medicine, in print.
  21. Henchcliffe C, Beal MF; Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol. 2008 Nov;4(11):600-9.
  22. Mancini A, Corbo GM, Gaballo A, et al; Relationships between plasma CoQ10 levels and thyroid hormones in chronic obstructive pulmonary disease.; Biofactors. 2005;25(1-4):201-4
  23. Mancini A, De Marinis L, Littarru GP, et al; An update of Coenzyme Q10 implications in male infertility: biochemical and therapeutic aspects.; Biofactors. 2005;25(1-4):165-74.
  24. Ikematsu H, Nakamura K, Harashima S, et al; Safety assessment of coenzyme Q10 (Kaneka Q10) in healthy subjects: a double-blind, randomized, placebo-controlled trial.; Regul Toxicol Pharmacol. 2006 Apr;44(3):212-8. Epub 2006 Jan 23.
  25. Singh RB, Niaz MA, Kumar A, et al; Effect on absorption and oxidative stress of different oral Coenzyme Q10 dosages and intake strategy in healthy men.; Biofactors. 2005;25(1-4):219-24.
  26. Hodgson JM, Watts GF, Playford DA, Burke V, Croft KD. Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes. European Journal of Clinical Nutrition. 56.11 (2002):1137-42.
  27. Hanioka T, Tanaka M, Ojima M, Shizukuishi S, Folkers K. Effect of topical application of coenzyme Q10 on adult periodontitis. Molecular Aspects of Medicine. 15 Suppl (1994):241-8.